Effects of chronic guanethidine treatment and adrenal medullectomy on plasma levels of catecholamines and corticosterone in forcibly immobilized rats.
D000313:Adrenal Medulla / Q000502:physiology*; D000818:Animals; D002395:Catecholamines / Q000097:blood*; D003345:Corticosterone / Q000097:blood*; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism; D006145:Guanethidine / Q000494:pharmacology*; D006801:Humans; D008297:Male; D010625:Phenylethanolamine N-Methyltransferase / Q000378:metabolism; D051381:Rats; D012149:Restraint, Physical; D013315:Stress, Psychological / Q000097:blood*; D013564:Sympathetic Nervous System / Q000187:drug effects; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D002395:Catecholamines; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D010625:Phenylethanolamine N-Methyltransferase; D003345:Corticosterone; D006145:Guanethidine